Orion Corporation: Managers’ transactions – Mikko Kemppainen

Group 1 - Orion Corporation has reported a transaction involving shares by Mikko Kemppainen, a senior manager, who received a share-based incentive of 3,685 shares at a unit price of 0 EUR on March 10, 2026 [1] - The transaction is categorized as an initial notification under the Market Abuse Regulation (EU) No 596/2014 [1] - The aggregated transaction details indicate a volume-weighted average price of 0 EUR for the shares involved [1] Group 2 - Orion Pharma, a subsidiary of Orion Corporation, is a Nordic pharmaceutical company with over a century of experience in developing, manufacturing, and marketing pharmaceuticals and active pharmaceutical ingredients [2] - The company reported net sales of EUR 1,890 million in 2025 and employs approximately 4,000 professionals globally [2] - Orion Pharma focuses on key therapy areas such as oncology and pain, with proprietary products aimed at treating cancer, respiratory diseases, and neurological diseases [2]